Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -613.95%-614K | -164.37%-920K | 88.10%-175K | 47.64%-2.23M | 79.31%-325K | 94.71%-86K | -42.62%-348K | -79.93%-1.47M | -98.37%-4.26M | -280.39%-1.57M |
| Net income from continuing operations | -94.51%-2.62M | 89.73%-162K | 16.28%-1.56M | -113.27%-7.65M | -3,709.33%-2.86M | 25.32%-1.35M | -93.38%-1.58M | -109.54%-1.87M | 39.41%-3.59M | 69.39%-75K |
| Operating gains losses | 130.56%77K | -769.68%-1.26M | -108.01%-29K | 383.01%1.45M | 387.03%1.15M | -169.81%-252K | 168.12%188K | 284.69%362K | -186.20%-512K | -182.39%-401K |
| Depreciation and amortization | 0.00%1K | 0.00%2K | 0.00%1K | 0.00%5K | 0.00%1K | -50.00%1K | 100.00%2K | 0.00%1K | 0.00%5K | 0.00%1K |
| Remuneration paid in stock | ---- | ---- | ---- | 63.03%-295K | ---- | ---- | ---- | ---- | -169.59%-798K | ---- |
| Other non cashItems | 34.45%1.49M | 25.05%1.31M | 33.80%1.25M | 47.78%4.29M | 79.58%1.2M | -0.18%1.11M | 110.84%1.05M | 48.89%935K | 81.21%2.9M | 280.57%666K |
| Change In working capital | 8.66%439K | -8,040.00%-814K | 118.31%165K | 98.77%-28K | 149.69%479K | 131.22%404K | -102.87%-10K | -150.97%-901K | -221.35%-2.27M | -1,125.53%-964K |
| -Change in receivables | 300.00%8K | 0.00%9K | -25.00%-10K | -200.00%-6K | -200.00%-9K | 100.00%2K | 175.00%9K | -200.00%-8K | 300.00%6K | 212.50%9K |
| -Change in prepaid assets | 38.46%90K | -205.80%-73K | 41.57%-97K | 2,600.00%25K | -35.23%57K | -38.68%65K | 3,350.00%69K | 15.74%-166K | -109.09%-1K | 158.82%88K |
| -Change in payables and accrued expense | -16.02%283K | -864.77%-849K | 137.41%272K | 97.77%-47K | 140.62%431K | 127.27%337K | -145.36%-88K | -14,440.00%-727K | -207.50%-2.11M | -731.55%-1.06M |
| -Change in other current liabilities | ---- | ---- | ---- | --0 | --0 | ---- | ---- | --0 | -65.00%-165K | --0 |
| -Change in other working capital | --58K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -613.95%-614K | -164.37%-920K | 88.10%-175K | 47.64%-2.23M | 79.31%-325K | 94.71%-86K | -42.62%-348K | -79.93%-1.47M | -98.37%-4.26M | -280.39%-1.57M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -32.98%126K | 126K | 0 | 0 | 0 | 188K | 0 | |||
| Net PPE purchase and sale | ---- | ---- | ---- | -32.98%126K | --126K | --0 | --0 | --0 | --188K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | ---- | -32.98%126K | --126K | --0 | --0 | --0 | --188K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 4.01M | 53.72%1.05M | 0 | -39.53%2.03M | 0 | 0 | 685K | 1.35M | 3.36M | 227K |
| Net issuance payments of debt | ---1.22M | 53.72%1.05M | --0 | -39.53%2.03M | --0 | --0 | --685K | --1.35M | --3.36M | --227K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --4.01M | 53.72%1.05M | --0 | -39.53%2.03M | --0 | --0 | --685K | --1.35M | --3.36M | --227K |
| Net cash flow | ||||||||||
| Beginning cash position | -67.20%165K | -78.95%36K | -28.37%207K | -69.51%289K | -73.27%420K | 639.71%503K | -46.56%171K | -69.51%289K | -69.40%948K | 15.43%1.57M |
| Current changes in cash | 4,124.42%3.46M | -60.53%133K | -43.44%-175K | 90.10%-70K | 85.19%-199K | -105.70%-86K | 238.11%337K | 80.60%-122K | 67.05%-707K | -225.42%-1.34M |
| Effect of exchange rate changes | 133.33%7K | 20.00%-4K | 0.00%4K | -125.00%-12K | -122.58%-14K | 142.86%3K | 37.50%-5K | 300.00%4K | 1,300.00%48K | --62K |
| End cash Position | 765.00%3.63M | -67.20%165K | -78.95%36K | -28.37%207K | -28.37%207K | -73.27%420K | 639.71%503K | -46.56%171K | -69.51%289K | -69.51%289K |
| Free cash from | -613.95%-614K | -164.37%-920K | 88.10%-175K | 47.64%-2.23M | 79.31%-325K | 94.71%-86K | -42.62%-348K | -79.93%-1.47M | -98.37%-4.26M | -280.39%-1.57M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.